3H Biomedical

Uppsala, Sweden Founded: 2004 • Age: 22 yrs
Diversified research solutions in cell culture technologies are provided.

About 3H Biomedical

Founded in 2004 in Uppsala, Sweden, operations are focused on the biomedical research sector. Primary cells, cell culture media, RNA, DNA, cellular products, and cell-based assays are manufactured and sold for research, drug discovery, and tissue engineering. Human cell models such as primary adipose, adrenal cortical, auditory, cardiac, and dermal cells are offered, along with animal cell models, immortalized cells, biospecimens, reagents, consumables, and molecular biology products.

  • Headquarter Uppsala, Sweden
  • Sectors
    Healthcare
  • Email
    β€’β€’β€’β€’β€’β€’β€’β€’
  • Website 3hbiomedical.com
  • Social LinkedIn

People of 3H Biomedical

2 people are tracked at 3H Biomedical (2 in leadership).

NameRoleGroup
Anders Gobl
OwnerLeadership
Mallen Huang
CEOLeadership
Premium access

Complete people profiles for 3H Biomedical

Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.

  • Full employee list
  • Team structure
  • Board tenure
  • Professional contacts

Verified entity values are shown only after access is granted.

Web traffic of 3H Biomedical

The website of 3H Biomedical (3hbiomedical.com) receives about 6.1K visits a month.

  • Monthly visits
    6.1K

    ▲ 10.6% vs previous month

Similar websites

Websites whose visitors overlap most with 3H Biomedical. Affinity shows how closely the audiences match.

WebsiteDomainAudience affinityMonthly visitsGlobal rankProfile
echelon-inc.com
96%
42.3K#789,218View details
antibodiesinc.com
92%
21K#1,321,745View details
psi.cz
86%
11.3K#1,954,414View details
prosci-inc.com
67%
9K#2,233,496View details
trilinkbiotech.com
64%
29.9K#920,436View details

Similar companies to 3H Biomedical

10 companies that operate in the same segment as 3H Biomedical (Life Sciences Platforms & Tools), ranked by their profile score on The Company Check.

CompanyDescriptionFoundedLocationTotal fundingRevenueEmployees
Medidata is recognized as a leading provider of SaaS solutions for clinical research.
1999New York, New York, United StatesUSD 41.5 M––
AI-based solutions for health management are provided.
2015Dallas, Texas, United StatesUSD 2.8 B––
Nanopore-based electronic systems for single-molecule analysis are developed.
2005Oxford, Oxfordshire, United KingdomUSD 1.3 BUSD 301.49 M1,480
Real-world health data is provided for research and decisions.
2012Menlo Park, California, United StatesUSD 259.16 M––
Genetically modified cell lines are developed using AAV gene-editing platform.
2007Cambridge, Cambridgeshire, United KingdomUSD 46.29 M––
Biological reagents and antibodies are developed for life science research.
1998Cambridge, Cambridgeshire, United KingdomUSD 78.8 M––
Electron microscopy services and microanalysis instruments are provided.
1956Waltham, Massachusetts, United States–USD 44.56 B125,000
Novel therapeutics are discovered using an AI-enabled drug platform.
2013New York, New York, United StatesUSD 456.66 MUSD 74.68 M–
A platform for sharing and accessing academic research papers is provided.
2008San Francisco, California, United StatesUSD 58.4 M––
Developer of molecular diagnostic testing solutions
1996Sunnyvale, California, United StatesUSD 19.1 MUSD 54.88 M208
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Frequently Asked Questions about 3H Biomedical

3H Biomedical was founded in 2004.

3H Biomedical is headquartered in Uppsala, Sweden. It is registered at Uppsala, Uppsala County, Sweden.

Mallen Huang is the current CEO of 3H Biomedical.

Founded in 2004 in Uppsala, Sweden, operations are focused on the biomedical research sector. Primary cells, cell culture media, RNA, DNA, cellular products, and cell-based assays are manufactured and sold for research, drug discovery, and tissue engineering. Human cell models such as primary adipose, adrenal cortical, auditory, cardiac, and dermal cells are offered, along with animal cell models, immortalized cells, biospecimens, reagents, consumables, and molecular biology products.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available